5,6-dihydrothieno[3,4-h]quinazoline compound
Grant
US12577253B2
Kind: B2
Mar 17, 2026
Assignee
SHANGHAI FOSUN PHARMACEUTICAL INDUSTRIAL DEVELOPMENT CO., LTD.
Inventors
Yangyang Xu, Wentao Wu, Haizhong Tan, Dongkai Zhang, Jikui Sun, Yang Zhang, Shuhui Chen
Abstract
Provided are a series of 5,6-dihydrothieno[3,4-h]quinazoline compounds as represented by formula (P) and pharmaceutically acceptable salts thereof, and the use of the compounds or pharmaceutically acceptable salts thereof in the preparation of solid tumor drugs, such as solid tumor drugs associated with selective PLK1 inhibitors.
CPC Classifications
C07D 495/04
C07D 519/00
A61P 35/00
Filing Date
2022-01-26
Application No.
18276226
Claims
13